4月25日 - ** 泰诺制药公司 Kenvue KVUE.N 股价上涨 2.13% 至 23.24 美元
** 金融时报》援引熟悉内情的人士的话报道，丹-勒布的Third Point基金已持有该公司股份。
** 金融时报》称，Third Point 的持股规模以及该对冲基金与 Kenvue 的接触程度无法立即确定。
** Kenvue没有立即回应路透的置评请求
** 今年 3 月，作为与激进投资者 Starboard Value 达成的协议的一部分，Kenvue 任命 (link) 三位新董事进入董事会。
** 截至上次收盘，股价年累计上涨了9.7%。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.